2025 年 12 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603717 证券简称：天域生物 公告编号：2026-008 天域生物科技股份有限公司 月份 销售数量（万头） 销售收入（万元） 期末库存量 当月 累计 当月 累计 （万头） 2025 年 1 月 3.94 3.94 6,115.20 6,115.20 17.01 2025 年 2 月 3.12 7.06 4,270.88 10,386.08 15.14 2025 年 3 月 4.16 11.25 7,047.03 17,433.11 14.00 2025 年 4 月 3.51 14.76 5,932.95 23,366.06 13.32 2025 年 5 月 2.48 17.24 4,038.75 27,404.81 14.14 2025 年 6 月 3.18 20.42 3,748.42 31,153.23 14.44 2025 年 7 月 1.72 22.14 2,103.14 33,256.37 16.38 202 ...

人民财讯1月9日电，天域生物（603717）1月9日公告，2025年12月，公司销售生猪3.92万头，销售收入 4468.62万元，环比变动分别为122.41%、83.72%，同比变动分别为39.48%、-24.74%。2025年1-12月， 公司累计销售生猪37.88万头，同比上升22.92%；累计销售收入51920.70万元，同比下降10.38%。2025 年12月末，公司生猪存栏20.42万头，同比上升13.65%，环比上升8.65%。 ...

Core Points - The company has returned a total of RMB 61.5 million of idle raised funds to the special account for raised funds as of January 7, 2026 [1] - The company has decided to permanently transfer all remaining raised funds from the terminated project "Tianchang Longgang Red Cultural Tourism Scenic Area Project" to its own funds account and has completed the cancellation of the raised funds special account [1] Fundraising Basic Situation - The company raised a total of RMB 402.27 million by issuing 48.35 million shares at a price of RMB 8.32 per share, with a net amount of RMB 393.87 million after deducting issuance costs [1] - The raised funds have been fully received and verified by an accounting firm [1] Fundraising Storage and Management - The company has established special accounts for raised funds at Nanyang Commercial Bank and HSBC Bank, and signed a tripartite supervision agreement with the sponsor [2] Temporary Supplement of Working Capital - The company approved the temporary use of up to RMB 61.5 million of idle raised funds for working capital, with a usage period not exceeding 12 months [3] - The company returned RMB 2 million of the temporary working capital on September 23, 2025, and the remaining RMB 59.5 million was returned by January 7, 2026 [4][5] Cancellation of Special Accounts - The company has terminated the fundraising investment project and decided to use the remaining funds for permanent working capital [5] - After returning all idle funds to the special account, the company transferred RMB 59,500,484.01 to its own funds account and completed the cancellation of the special account [5][6]

证券代码：603717 证券简称：天域生物 公告编号：2026-007 天域生物科技股份有限公司 关于归还临时补充流动资金的募集资金 并注销募集资金专项账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 同日，公司根据第五届董事会第五次会议、2026 年第一次临时股东会 决议，将募投项目"天长市龙岗红色古镇文化旅游景区工程总承包项目"终 止后所对应募集资金专户中剩余募集资金全部划转至公司自有资金账户永久 补充流动资金，并完成募集资金专户注销手续。 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于核准天域生态环境股份有限公司非 公开发行股票的批复》（证监许可[2021]101号），天域生物科技股份有限公司 （以下简称"公司"，曾用名"天域生态环境股份有限公司"）向特定对象发行 人民币普通股（A股）股票4,835万股，每股发行价格为人民币8.32元，本次非公 开发行股票募集资金总额为人民币402,272,000.00元，扣除不含税各项发行费用 人 民 币 8,406,457.62 元 ， 本 次 非 公 开 发 ...

Group 1 - The chairman of Tianyu Bio, Luo Weiguo, has resigned from his positions due to work adjustments, but will continue to serve as a director and manager of the company's subsidiaries [1] - Meng Zhuowei, a board member and the current president, will temporarily assume the role of chairman until a new chairman is elected [1] - Luo Weiguo has been the chairman of Tianyu Bio for over 12 years and currently holds approximately 37.25 million shares, accounting for 12.84% of the company's total equity [4] Group 2 - Six days prior to the resignation announcement, Tianyu Bio disclosed that Luo Weiguo was under investigation by the China Securities Regulatory Commission (CSRC) for suspected illegal stock reduction [4] - The company has faced continuous financial losses over the past five years, with cumulative losses reaching 1.25 billion CNY [5] - For the first three quarters of 2025, Tianyu Bio reported total revenue of 536 million CNY, a year-on-year decrease of 14.23%, and a net loss of 1.61 million CNY [5] Group 3 - As of January 7, 2026, Tianyu Bio's stock price was 7.80 CNY per share, with a total market capitalization of 2.26 billion CNY [6]

Core Viewpoint - Tianyu Bio's chairman, Luo Weiguo, has resigned from multiple positions following a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into his alleged illegal stock reduction activities [1][3]. Group 1: Company Leadership Changes - Luo Weiguo submitted a resignation report to the board, stepping down as chairman, director, and member of various committees due to work adjustments [1]. - Luo will continue to serve as a director and manager at the company's subsidiary, Sichuan Zhongtai Qihang New Energy Technology Co., Ltd., and at Shanghai Tianyu New Energy Technology Co., Ltd. [1]. Group 2: Business Overview - Tianyu Bio is based in Chongqing and operates in diverse sectors, including ecological agriculture and energy, with a focus on pig farming and distributed photovoltaic power generation [2]. - The company employs a self-breeding and "company + farmer" model for pig farming, primarily concentrating its operations in Hubei Province [2]. - In the energy sector, Tianyu Bio invests in distributed photovoltaic projects, generating stable income from power generation and potential profits from selling power stations [2]. Group 3: Financial Performance - The company has reported continuous losses over the past five years, with total losses amounting to 1.57 billion yuan, 2.15 billion yuan, 3.12 billion yuan, 4.62 billion yuan, and 1.07 billion yuan from 2020 to 2024 [3]. - In the first three quarters of 2025, the company approached breakeven, aided by a 24 million yuan gain from the disposal of non-current assets, although the net profit excluding non-recurring items was -34.16 million yuan [3]. Group 4: Recent Developments - Prior to the investigation, Tianyu Bio's 4.65 billion yuan private placement application was accepted by the Shanghai Stock Exchange, aiming to raise funds for working capital and debt repayment [4]. - The private placement involves issuing up to 71.0282 million shares at a price of 6.55 yuan per share, fully subscribed by an entity controlled by Luo Weiguo, which may enhance his control over the company [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 重要内容提示： 天域生物科技股份有限公司（以下简称"公司"）董事会于近日收到董事长罗卫国先生的书面辞职报告， 罗卫国先生因工作调整，申请辞去公司董事长、董事、审计委员会委员、提名委员会委员、薪酬与考核 委员会委员及战略与ESG委员会主任委员职务。辞任后，罗卫国先生将继续担任公司控股子公司四川中 泰启航新能源技术有限公司董事兼经理、上海天域新能源科技有限公司董事职务。具体情况如下： 一、提前离任的基本情况 证券代码：603717 证券简称：天域生物 公告编号：2026-006 天域生物科技股份有限公司 关于董事长离任暨推举董事代行董事长职责的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ■ 二、离任对公司的影响 根据《公司法》《公司章程》等相关规定，罗卫国先生的辞职报告自送达董事会之日起生效，其辞去公 司董事职务不会导致公司董事会成员低于法定最低人数，不会影响董事会正常运行和公司的正常经营。 后续罗卫国先生将按照公司相关制度规定做好交接工作。 截至本公告披露日，罗卫国先生 ...

证券代码：603717 证券简称：天域生物 公告编号：2026-006 天域生物科技股份有限公司 关于董事长离任暨推举董事代行董事长职责的公告 1 关制度规定做好交接工作。 截至本公告披露日，罗卫国先生持有公司股份 37,251,829 股，占公司总股本 比例为 12.84%。其辞任公司相关职务后，仍为公司持股 5%以上股东、实际控制 人，会继续关心和支持上市公司的可持续经营发展，其所持有的公司股份亦将严 格根据《上海证券交易所股票上市规则》《上市公司股东减持股份管理暂行办法》 《上海证券交易所上市公司自律监管指引第 15 号—股东及董事、高级管理人员 减持股份》等相关法律法规及其所作的相关承诺进行管理。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 天域生物科技股份有限公司（以下简称"公司"）董事会于近日收到董事长 罗卫国先生的书面辞职报告，罗卫国先生因工作调整，申请辞去公司董事长、董 事、审计委员会委员、提名委员会委员、薪酬与考核委员会委员及战略与 ESG 委员会主任委员职务。辞任后，罗卫国先生将继续担任 ...

证券代码：603717 证券简称：天域生物 公告编号：2026-005 天域生物科技股份有限公司 关于 2026 年度为合作养殖农户提供担保预计的 进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 本次担保 金额 | | 实际为养殖农户提 供的担保余额（不 含本次担保金额） | | 是否在前期 预计额度内 | 本次担保是 否有反担保 | | --- | --- | --- | --- | --- | --- | --- | | | 340.00 | 万元 | 1,150.00 | 万元 | 是 | 是 | | 被担保人名称 贺晓赢、阮媛媛 （夫妻关系） | | | | | | | 累计担保情况 | 对外担保逾期的累计金额（万元） | / | | --- | --- | | 截至本公告日上市公司及其控股子 | | | 公司对外担保总额（万元） | 103,651.59 | | （实际发生的担保余额，不含本次） | | | 对外担保总额占上市公司最近一期 | 199.81 | | ...

格隆汇1月6日丨天域生物(603717.SH)公布，公司董事会于近日收到董事长罗卫国先生的书面辞职报 告，罗卫国先生因工作调整，申请辞去公司董事长、董事、审计委员会委员、提名委员会委员、薪酬与 考核委员会委员及战略与ESG委员会主任委员职务。辞任后，罗卫国先生将继续担任公司控股子公司四 川中泰启航新能源技术有限公司董事兼经理、上海天域新能源科技有限公司董事职务。 为保证公司董事会正常运作及经营决策顺利开展，公司于2026年01月06日召开第五届董事会第六次会 议，审议通过《关于推举孟卓伟先生代行董事长职责的议案》，同意推举公司董事、总裁兼董事会秘书 孟卓伟先生暂代行董事长职责，直至选举产生新任董事长之日止。公司将按照相关法律法规及规范性文 件的规定，尽快完成新任董事长选举、新任董事补选和调整董事会专门委员会委员等工作。 ...